JournalsHub
.online
Find My Journal
DF

Daniel E. Fürst

University of California, Los Angeles US

ORCID 0000-0002-4018-7629
364
Publications
34,468
Citations
82
H-Index
236
i10-Index
5.38
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

359 total

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis PDF

Jasvinder A. Singh, Daniel E. Fürst, Aseem Bharat, Jeffrey R. Curtis, Arthur F. Kavanaugh et al. - Arthritis Care & Research, 2012
Cited by 1,797 OpenAlex

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials PDF

David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl et al. - Annals of the Rheumatic Diseases, 2011
Cited by 767 OpenAlex

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Daniel E. Fürst, Edward Keystone, Jürgen Braun, F. C. Breedveld, G. R. Burmester et al. - Annals of the Rheumatic Diseases, 2011
Cited by 691 OpenAlex

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis PDF

Jennifer M. Grossman, R D. Gordon, Veena K. Ranganath, Chad Deal, Liron Caplan et al. - Arthritis Care & Research, 2010
Cited by 711 OpenAlex

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

Christian Antoni, Arthur Kavanaugh, Bruce Kirkham, Zuhre Tutuncu, Gerd R Burmester et al. - Arthritis & Rheumatism, 2005
Cited by 641 OpenAlex

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

Ravinder N. Maini, FC Breedveld, Joachim R. Kalden, Josef S Smolen, Daniel E. Fürst et al. - Arthritis & Rheumatism, 2004
Cited by 521 OpenAlex

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis PDF

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld et al. - New England Journal of Medicine, 2000
Cited by 3,015 OpenAlex

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden et al. - The Lancet, 1999
Cited by 2,349 OpenAlex

Microchimerism and HLA-compatible relationships of pregnancy in scleroderma

J. Lee Nelson, Daniel E. Fürst, Sean Maloney, Ted Gooley, Paul C. Evans et al. - The Lancet, 1998
Cited by 597 OpenAlex

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

David T. Felson, Jennifer J. Anderson, Maarten Boers, Claire Bombardier, Daniel E. Fürst et al. - Arthritis & Rheumatism, 1995
Cited by 2,836 OpenAlex

Research Topics

Rheumatoid Arthritis Research and Therapies (170) Systemic Sclerosis and Related Diseases (112) Systemic Lupus Erythematosus Research (70) Autoimmune and Inflammatory Disorders Research (51) Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37)

Affiliations

Pepperdine University
US 1993 - 1993
Rutgers, The State University of New Jersey
US 2018 - 1989
University of New Brunswick
CA 1990 - 1990
Boston University
US 2000 - 2000
Goethe University Frankfurt
DE 2006 - 2006

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now